More Dangerous Mouthwashes and Hand Sanitizers Recalled
WEDNESDAY, Dec. 30, 2020 -- A hand sanitizer has been recalled because it may contain methanol, a toxic chemical known as wood alcohol, according to the U.S. Food and Drug Administration. In addition, a mouthwash is being recalled because it may be tainted with bacteria that are particularly dangerous for people with COVID-19.
Shane Erickson Inc. is recalling three brands of hand sanitizer because they may contain methanol, which can cause nausea, vomiting, headache, blurred vision, permanent blindness, seizures, coma, damage to the nervous system, or death, according to the FDA. "Although all persons using these products on their hands are at risk, young children who accidentally ingest these products, and adolescents and adults who drink these products as an alcohol (ethanol) substitute, are most at risk for methanol poisoning," the FDA notice said.
Made in China, the recalled products are packaged in a white opaque or clear plastic bottle with either a blue, clear, or black cap and are labeled as IMC Wash-Free Hand Sanitizer, Wash-Free Hand Sanitizer, and Thrifty White Pharmacy Hand Sanitizer.
In addition, the recall of GUM Paroex Chlorhexidine Gluconate Oral Rinse is being expanded after manufacturer Sunstar Americas learned of 29 infections. Using the contaminated mouthwash can result in "oral and, potentially, systemic infections requiring antibacterial therapy. In the most at-risk populations, the use of the defective product may result in life-threatening infections, such as pneumonia and bacteremia," the company said. "Use of the contaminated product on patients with preexisting respiratory conditions, including those infected with COVID-19, is particularly unsafe."
The recall covers 4-ounce and 1-pint (16-ounce) bottles, NDC Nos. 052376-021-04 and 052376-021-02, of the prescription oral rinse. The recall now includes all lots within the expiration date range from 12/31/20 to 9/30/22.
© 2021 HealthDay. All rights reserved.
Posted: December 2020
Read this next
MONDAY, Jan. 4, 2021 -- The cumulative three-year incidence of osteonecrosis of the jaw (ONJ) is 2.8 percent in cancer patients receiving zoledronic acid for metastatic bone...
WEDNESDAY, Dec. 30, 2020 -- Hospitalized adult patients with severe COVID-19 and secondary bloodstream infections (sBSIs) are more likely to have worse clinical outcomes,...
TUESDAY, Dec. 29, 2020 -- For women undergoing cesarean section, the risk for surgical site infection (SSI) is not increased when surgical antimicrobial prophylaxis (SAP) is...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.